BSE Live
Oct 01, 13:39Prev. Close
439.95
Open Price
443.10
Bid Price (Qty.)
452.30 (7)
Offer Price (Qty.)
455.85 (23)
NSE Live
Oct 01, 13:39Prev. Close
440.05
Open Price
445.05
Bid Price (Qty.)
452.75 (4)
Offer Price (Qty.)
455.40 (4)
Balance Sheet of Venus Remedies (in Rs. Cr.) | Mar 10 | Mar 09 | Mar 08 | Mar 07 | Mar 06 | |
12 mths | 12 mths | 12 mths | 12 mths | 12 mths | ||
EQUITIES AND LIABILITIES | ||||||
SHAREHOLDER'S FUNDS | ||||||
Equity Share Capital | 8.47 | 8.45 | 8.45 | 8.41 | 8.41 | |
Total Share Capital | 8.47 | 8.45 | 8.45 | 8.41 | 8.41 | |
Reserves and Surplus | 171.47 | 134.73 | 85.08 | 50.12 | 23.54 | |
Total Reserves and Surplus | 171.47 | 134.73 | 85.08 | 50.12 | 23.54 | |
Total Shareholders Funds | 179.95 | 143.18 | 93.54 | 58.53 | 31.95 | |
NON-CURRENT LIABILITIES | ||||||
Long Term Borrowings | 92.27 | 89.74 | 69.87 | 72.41 | 9.60 | |
Deferred Tax Liabilities [Net] | 7.58 | 5.99 | 4.18 | 2.07 | 1.27 | |
Other Long Term Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Provisions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Non-Current Liabilities | 99.85 | 95.73 | 74.05 | 74.48 | 10.87 | |
CURRENT LIABILITIES | ||||||
Short Term Borrowings | 57.12 | 41.86 | 25.85 | 12.59 | 11.99 | |
Trade Payables | 4.80 | 4.17 | 3.66 | 1.92 | 2.84 | |
Other Current Liabilities | 4.48 | 4.58 | 4.04 | 2.91 | 0.81 | |
Short Term Provisions | 13.18 | 9.17 | 10.63 | 8.51 | 3.83 | |
Total Current Liabilities | 79.58 | 59.78 | 44.18 | 25.93 | 19.46 | |
Total Capital And Liabilities | 359.40 | 298.71 | 211.77 | 158.96 | 62.28 | |
ASSETS | ||||||
NON-CURRENT ASSETS | ||||||
Tangible Assets | 210.84 | 126.70 | 109.95 | 44.15 | 23.23 | |
Intangible Assets | 0.00 | 43.47 | 9.33 | 6.68 | 0.21 | |
Capital Work-In-Progress | 0.86 | 0.86 | 1.40 | 41.74 | 6.38 | |
Other Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Fixed Assets | 211.69 | 171.03 | 120.68 | 92.57 | 29.83 | |
Non-Current Investments | 24.79 | 24.79 | 24.47 | 23.02 | 2.07 | |
Deferred Tax Assets [Net] | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Long Term Loans And Advances | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Other Non-Current Assets | 1.07 | 2.34 | 3.75 | 5.23 | 4.38 | |
Total Non-Current Assets | 237.55 | 198.16 | 148.90 | 120.82 | 36.28 | |
CURRENT ASSETS | ||||||
Current Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Inventories | 61.94 | 44.58 | 27.78 | 18.08 | 14.27 | |
Trade Receivables | 31.93 | 30.92 | 16.49 | 9.39 | 7.56 | |
Cash And Cash Equivalents | 2.00 | 1.29 | 1.05 | 2.92 | 0.56 | |
Short Term Loans And Advances | 25.97 | 23.77 | 17.55 | 7.75 | 3.62 | |
OtherCurrentAssets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Total Current Assets | 121.85 | 100.56 | 62.86 | 38.13 | 26.00 | |
Total Assets | 359.40 | 298.71 | 211.77 | 158.96 | 62.28 | |
OTHER ADDITIONAL INFORMATION | ||||||
CONTINGENT LIABILITIES, COMMITMENTS | ||||||
Contingent Liabilities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
CIF VALUE OF IMPORTS | ||||||
Raw Materials | 25.36 | 21.98 | 18.24 | 7.92 | 1.18 | |
Stores, Spares And Loose Tools | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Trade/Other Goods | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Capital Goods | 0.63 | 1.12 | 1.76 | 1.64 | 0.18 | |
EXPENDITURE IN FOREIGN EXCHANGE | ||||||
Expenditure In Foreign Currency | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
REMITTANCES IN FOREIGN CURRENCIES FOR DIVIDENDS | ||||||
Dividend Remittance In Foreign Currency | -- | -- | -- | -- | -- | |
EARNINGS IN FOREIGN EXCHANGE | ||||||
FOB Value Of Goods | -- | -- | -- | -- | -- | |
Other Earnings | -- | -- | -- | -- | -- | |
BONUS DETAILS | ||||||
Bonus Equity Share Capital | -- | -- | -- | -- | -- | |
NON-CURRENT INVESTMENTS | ||||||
Non-Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Non-Current Investments Unquoted Book Value | 24.79 | 24.79 | 24.47 | 23.02 | 2.07 | |
CURRENT INVESTMENTS | ||||||
Current Investments Quoted Market Value | -- | -- | -- | -- | -- | |
Current Investments Unquoted Book Value | -- | -- | -- | -- | -- |
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y
12.08.2025
Venus Remedies Consolidated June 2025 Net Sales at Rs 131.90 crore, up 21.44% Y-o-Y
05.08.2025
Venus Remedies Standalone June 2025 Net Sales at Rs 131.85 crore, up 24.55% Y-o-Y
28.05.2025
Venus Remedies Standalone March 2025 Net Sales at Rs 194.04 crore, up 10.78% Y-o-Y
05.02.2025
Venus Remedies Standalone December 2024 Net Sales at Rs 172.54 crore, up 31.48% Y-o-Y